Skip to main content
Clinical Trials/EUCTR2008-000511-16-GB
EUCTR2008-000511-16-GB
Active, not recruiting
Phase 1

Management of Asthma in School age Children On Therapy - MASCOT

Keele University0 sites450 target enrollmentApril 18, 2008

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Chronic asthma (paediatric population)
Sponsor
Keele University
Enrollment
450
Status
Active, not recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 18, 2008
End Date
June 24, 2010
Last Updated
6 years ago
Study Type
Interventional clinical trial of medicinal product

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\.Children with physician diagnosed asthma aged 6 years \-14 years, 11months
  • 2\.Those requiring frequent short\-acting beta2 agonist relief therapy \= 7 puffs per week
  • 3\.Those with symptoms of asthma (i.e. wheeze, shortness of breath but not cough alone) resulting in:
  • i.Nocturnal wakening in the last week because of asthma symptoms and/or
  • ii.Asthma has interfered with usual activities in the last week and/or
  • iii.Those who have had exacerbations, defined as a short course of oral corticosteroids, an unscheduled GP or A\&E Department visit or a hospital admission within the previous 6 months.
  • 4\.Fully informed written (proxy) consent and assent, where appropriate
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) no

Exclusion Criteria

  • 1\.Children receiving long acting beta2\-agonists, leukotriene receptor antagonists, regular theophylline therapy or high dose ICS (\>1000micrograms and unlicensed beclometasone dipropionate or equivalent at the discretion of the investigator).
  • 2\.Children with other respiratory diseases, cystic fibrosis, cardiac disease or immunological disorders.
  • 3\.Non\-English speaking

Outcomes

Primary Outcomes

Not specified

Similar Trials